메뉴 건너뛰기




Volumn 25, Issue 3, 2013, Pages

Experience with intramuscular zuclopenthixol and medroxyprogesterone acetate in the treatment of agitation and aggression in Huntington's disease

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; MEDROXYPROGESTERONE ACETATE; RISPERIDONE; VENLAFAXINE; ZUCLOPENTHIXOL;

EID: 84883861603     PISSN: 08950172     EISSN: 15457222     Source Type: Journal    
DOI: 10.1176/appi.neuropsych.12070164     Document Type: Letter
Times cited : (3)

References (3)
  • 1
    • 78650587544 scopus 로고    scopus 로고
    • Cyproterone to treat aggressivity in dementia: A clinical case and systematic review
    • Bolea-Alamanac BM, Davies SJ, Christmas DM, et al: Cyproterone to treat aggressivity in dementia: a clinical case and systematic review. J Psychopharmacol 2011; 25:141-145
    • (2011) J Psychopharmacol , vol.25 , pp. 141-145
    • Bolea-Alamanac, B.M.1    Davies, S.J.2    Christmas, D.M.3
  • 2
    • 79951513261 scopus 로고    scopus 로고
    • Risperidone long-acting injection and Huntington's disease: Case series with significant psychiatric and behavioural symptoms
    • Johnston TG: Risperidone long-acting injection and Huntington's disease: case series with significant psychiatric and behavioural symptoms. Int Clin Psychopharmacol 2011; 26:114-119
    • (2011) Int Clin Psychopharmacol , vol.26 , pp. 114-119
    • Johnston, T.G.1
  • 3
    • 84863115465 scopus 로고    scopus 로고
    • Risk of mortality among individual antipsychotics in patients with dementia
    • Kales HC, Kim HM, Zivin K, et al: Risk of mortality among individual antipsychotics in patients with dementia. Am J Psychiatry 2012; 169:71-79
    • (2012) Am J Psychiatry , vol.169 , pp. 71-79
    • Kales, H.C.1    Kim, H.M.2    Zivin, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.